Abstract
The metabolism of the bladder carcinogen N-nitroso-di-n-butylamine (NDBA) was studied in microsomal preparations of tissues of patients of both sexes, aged 59–69 years undergoing abdominal surgery. Samples of liver, ileum, and colon were of normal histological appearance. For comparison, samples of rat liver and small intestinal mucosa microsomes were included in the study.
Using 1-14C-labeled NDBA, the biotransformation to hydroxylation products retaining the nitroso group, NDBA-2-OH, NDBA-3-OH, and NDBA-4-OH, respectively, was investigated by reversed phase HPLC. In order to separate these metabolites, pooled samples were analysed by normal phase HPLC.
The rate of hydroxylation of NDBA was found to be 5.5 times higher in rat liver microsomes compared to those from human liver (2.86±0.29 vs 0.52±0.03 nM x min−1 x mg−1). NDBA-3-OH proved to be the major metabolite formed (>80% of total metabolites).
The metabolism of NDBA was low but detectable in seven out of nine specimens of human gut, 0.1–0.5 nM x mg−1 in 1 h of incubation, and of the same order of magnitude in rat intestinal tissue (0.4–0.6 nM x mg−1).
References
Borm PJA (1984) Oxidative drug metabolism in the rat gut wall in vitro. Correlation with in vivo data. Ph. D. thesis, State University of Utrecht, Netherlands
Druckrey H, Preussman R, Ivankovic S, Schmähl D (1967) Organotrope Wirkungen bei 65 verschiedenen N-nitroso-Verbindungen an BD-Ratten. Z Krebsforsch 69: 103–201
Janzowski C, Gottfried J, Eisenbrand G, Preussmann R (1982) Fluoro-substituted N-nitrosamines. 3. Microsomal metabolism of N-nitrosodibutylamine and of fluorinated analogs. Carcinogenesis 3: 777–780
Lowry AH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193: 265–275
Okada M, Suzuki E, Hashimoto Y (1976) Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N-dibutylnitrosamine in ACI/N rats. Gann 67: 825–834
Richter E, Feng X, Wiessler M (1985) Biotransformation of symmetric dialkylnitrosamines in the rat intestine. Biochem Pharmacol 34:445–446
Stohs SJ, Grafström RC, Burke MD, Moldeus PW, Orrenius SG (1976) The isolation of rat intestinal microsomes with stable cytochrome P-450 and their metabolism of benzo(a)pyrene. Arch Biochem Biophys 177: 105–116
Suzuki E, Anjo T, Aoki J, Okada M (1983a) Species variation in the metabolism of N-butyl-N-(4-hydroxybutyl)nitrosamine and related compounds in relation to urinary bladder carcinogenesis. Gann 74: 60–68
Suzuki E, Iiyoshi M, Okada M (1980) Nuclear magnetic resonance spectra of N-alkyl-N-(hydroxy- and oxo-alkyl)nitrosamines and chromatographic separation of their (Z)- and (E)-conformers. Chem Pharm Bull 28: 979–983
Suzuki E, Mochizuki M, Shibuya K, Okada M (1983b) N-N-dibutylnitrosamine metabolism by rat liver S9 fraction and oxidation by chemical model systems. Gann 74: 41–50
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pacifici, G.M., Richter, E., Lehmann, G. et al. Hydroxylation of dibutylnitrosamine in the human liver and intestinal microsomal fractions. Arch Toxicol 58, 196–198 (1986). https://doi.org/10.1007/BF00340981
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00340981